Durant Hma LLC
Durant Hma LLC was paid $12.99M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
DURANT, OK 74701
Next to other General Acute Care Hospital providers in Oklahoma
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,661 | $1.01M | |
| 2019 | 21,351 | $1.28M | |
| 2020 | 19,811 | $1.21M | |
| 2021 | 29,831 | $1.73M | |
| 2022 | 49,467 | $2.60M | |
| 2023 | 51,743 | $3.00M | |
| 2024incomplete | 32,192 | $2.17M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 26,730 | 26,374 | $4.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 13,808 | 13,603 | $3.24M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 2,200 | 2,136 | $656K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 5,104 | 5,014 | $637K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.7% | 3,044 | 1,568 | $485K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.1% | 8,503 | 8,437 | $399K |
| 80053 | Comprehensive metabolic panel | 3.0% | 16,061 | 15,459 | $393K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.0% | 7,342 | 7,278 | $388K |
| 62323 | 2.2% | 1,001 | 970 | $282K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 3,395 | 3,343 | $242K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 2,404 | 2,384 | $228K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.4% | 232 | 182 | $176K |
88 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 11,825 | $174K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 3,698 | $171K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.3% | 43 | $163K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 20,092 | $130K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,242 | $108K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,388 | $102K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,943 | $90K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,280 | $72K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 871 | $59K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,841 | $57K |
| 87070 | <1% | 4,957 | $57K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 345 | $52K |
| 86756 | <1% | 2,033 | $43K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 750 | $42K |
| 84703 | <1% | 3,589 | $33K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,433 | $33K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 345 | $28K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 169 | $22K |
| 84484 | <1% | 2,035 | $21K | |
| 81003 | <1% | 7,817 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 349 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 826 | $12K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 282 | $11K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 109 | $9K |
| 82553 | <1% | 935 | $9K | |
| 81001 | <1% | 2,893 | $9K | |
| 83690 | <1% | 1,620 | $9K | |
| 62321 | <1% | 25 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,097 | $8K |
| 82550 | <1% | 1,174 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,462 | $4K |
| 86850 | <1% | 537 | $4K | |
| 93458 | <1% | 13 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,865 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,111 | $4K |
| 93976 | <1% | 35 | $3K | |
| 85610 | <1% | 822 | $3K | |
| 85730 | <1% | 553 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 151 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 70 | $2K |
| 86803 | <1% | 166 | $2K | |
| 86762 | <1% | 163 | $2K | |
| 87340 | <1% | 197 | $2K | |
| 86592 | <1% | 499 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 278 | $2K |
| 87390 | <1% | 80 | $2K | |
| 86787 | <1% | 139 | $2K | |
| 86900 | <1% | 471 | $1K | |
| 86901 | <1% | 482 | $1K | |
| 87428 | <1% | 40 | $990.14 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,158 | $845.60 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $821.72 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $662.58 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $582.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 491 | $525.08 |
| 86703 | <1% | 63 | $515.77 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 25 | $488.69 |
| 84481 | <1% | 28 | $467.39 | |
| 84439 | <1% | 53 | $462.21 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 138 | $403.53 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $394.31 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 50 | $376.50 |
| 82947 | <1% | 102 | $353.37 | |
| 74019 | <1% | 12 | $234.72 | |
| 82747 | <1% | 13 | $230.61 | |
| 82607 | <1% | 13 | $200.82 | |
| 82247 | <1% | 36 | $182.78 | |
| 82150 | <1% | 29 | $160.62 | |
| 86708 | <1% | 12 | $152.43 | |
| 86705 | <1% | 12 | $144.92 | |
| 83605 | <1% | 13 | $133.20 | |
| 86706 | <1% | 12 | $123.64 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $115.52 |
| 85378 | <1% | 12 | $95.15 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 12 | $90.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 17 | $62.40 |
| 83735 | <1% | 12 | $59.60 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 940 | $17.03 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 88 | $9.54 |
| 99153 | Mod sedat endo service >5yrs | 0% | 95 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 310 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 79 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 633 | $0.00 |
| 99152 | 0% | 258 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 185 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 103 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.